A comparison of low-dose cyclophosphamide treatment with artemisinin treatment in reducing the number of regulatory T cells in murine breast cancer model.
about
Sesquiterpene Lactones from Artemisia Genus: Biological Activities and Methods of AnalysisUp-regulation of Th17 cells may underlie inhibition of Treg development caused by immunization with activated syngeneic T cells.Development of artemisinin compounds for cancer treatment.Protection against autoimmune diabetes by silkworm-produced GFP-tagged CTB-insulin fusion protein.BCc1, the novel antineoplastic nanocomplex, showed potent anticancer effects in vitro and in vivo.A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice.The effect of metronomic versus standard chemotherapy on the regulatory to effector T-cell equilibrium in cancer patients.Targeting Tregs in Malignant Brain Cancer: Overcoming IDO.Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives.Application of arteether-loaded polyurethane nanomicelles to induce immune response in breast cancer model.Evaluation of anti-cancer and immunomodulatory effects of carnosol in a Balb/c WEHI-164 fibrosarcoma model.Artemisinin rewires the protein interaction network in cancer cells: network analysis, pathway identification, and target prediction.Clinical and immunomodulatory effects of toceranib combined with low-dose cyclophosphamide in dogs with cancer.More insights into the pharmacological effects of artemisinin.Transcriptome analysis of genes associated with breast cancer cell motility in response to Artemisinin treatment.Antitumor Research on Artemisinin and Its Bioactive Derivatives.
P2860
Q26780167-AB1DE379-38A1-4C04-98BB-F19E81B987FBQ34075574-D1B06F3C-DB32-482A-A50B-50B30FE69D05Q34296810-A7A92E46-7394-42A4-9089-DB9A34B749C4Q35101668-876AD94B-E9E3-426B-AF7B-FE20B4ED2040Q36425426-1EA1029A-03D3-496F-B8A4-55BA4428F6B4Q36616446-D18C4843-9D82-4D5F-A677-18FFC62E6300Q37531844-C2542B59-E2B5-44F0-B6D2-98115DDEE4A3Q38110540-086A2DA8-389F-4575-9314-8875F608664CQ38756298-587A6903-B6DD-4ABD-8F9C-2FCEFC44657DQ38766425-501CF4DE-9185-4350-ACEF-693A194C89E7Q38975033-DE0F3300-51EB-4BE3-A306-E58DCD2990CDQ39089032-663A432A-3836-4892-BF51-F66EC1DA3B8BQ45875048-B55625B9-6529-4C7E-9D06-76F5CC8D70DAQ46250415-D6ECD563-C7C5-442D-A9B1-886C4586EF46Q47100761-3699BA1D-5BF1-4C4C-BC3C-B569E6B40A05Q52597265-51214E65-725B-4317-846A-CA88F5C5A6B0
P2860
A comparison of low-dose cyclophosphamide treatment with artemisinin treatment in reducing the number of regulatory T cells in murine breast cancer model.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
A comparison of low-dose cyclo ...... in murine breast cancer model.
@en
A comparison of low-dose cyclo ...... in murine breast cancer model.
@nl
type
label
A comparison of low-dose cyclo ...... in murine breast cancer model.
@en
A comparison of low-dose cyclo ...... in murine breast cancer model.
@nl
prefLabel
A comparison of low-dose cyclo ...... in murine breast cancer model.
@en
A comparison of low-dose cyclo ...... in murine breast cancer model.
@nl
P50
P1476
A comparison of low-dose cyclo ...... in murine breast cancer model
@en
P2093
Nafise Pakravan
Zuhir Muhammad Hassan
P304
P356
10.1016/J.INTIMP.2010.06.005
P577
2010-07-02T00:00:00Z